Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial.
BMC Cancer
; 12: 305, 2012 Jul 23.
Article
in En
| MEDLINE
| ID: mdl-22823994
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Radiosurgery
/
Neoplasms
Type of study:
Clinical_trials
/
Guideline
Limits:
Humans
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2012
Type:
Article
Affiliation country:
Canada